Latest Drug Approvals news
FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host After Allo-HSCT
posted December 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Tryngolza as Adjunct to Diet for Familial Chylomicronemia Syndrome
posted December 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Expands Approval of Vtama to Include Atopic Dermatitis
posted December 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Nemluvio for Moderate-to-Severe Atopic Dermatitis
posted December 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Risk for Herpes Zoster Elevated for Individuals With Atopic Dermatitis 
Early Respiratory Infections Linked to Atopic Dermatitis Diagnosis 
Review Shows Antihistamines Offer No Meaningful Benefit in Atopic Dermatitis Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
